Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, Canada

References

• GBD 2015 Chronic Respiratory Disease CollaboratorsGlobal, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015Lancet Respir Med20175969170628822787
   PubMed Web of Science ®Google Scholar
• Canadian Institute for Health InformationAll-Cause Readmission to Acute Care and Return to the Emergency DepartmentOttawa, Ont.CIHI2012
   Google Scholar
• WierLMElixhauserAPfuntnerAAuDHOverview of Hospitalizations among Patients with COPD, 2008. HCUP Statistical Brief #10622011Rockville, MDAgency for Healthcare Research and Quality Available from: http://www.hcup-us.ahrq.gov/reports/stat-briefs/sb106.pdfAccessed September 10, 2018
   Google Scholar
• ManninoDMBramanSThe epidemiology and economics of chronic obstructive pulmonary diseaseProc Am Thorac Soc20074750250617878461
   PubMedGoogle Scholar
• HillemanDEDewanNMaleskerMFriedmanMPharmacoeconomic evaluation of COPDChest200011851278128511083675
   PubMed Web of Science ®Google Scholar
• CelliBRMacNeeWAgustiAATS/ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
   PubMed Web of Science ®Google Scholar
• AnderssonFBorgSJanssonSAThe costs of exacerbations in chronic obstructive pulmonary disease (COPD)Respir Med200296970070812243316
   PubMed Web of Science ®Google Scholar
• ToyELGallagherKFStanleyELSwensenARDuhMSThe economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a reviewCOPD20107321422820486821
   PubMedGoogle Scholar
• MittmannNKuramotoLSeungSJHaddonJMBradley-KennedyCFitzgeraldJMThe cost of moderate and severe COPD exacerbations to the Canadian healthcare systemRespir Med2008102341342118086519
   PubMed Web of Science ®Google Scholar
• PasqualeMKSunSXSongFHartnettHJStemkowskiSAImpact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare populationInt J Chron Obstruct Pulmon Dis2012775776423152680
   PubMed Web of Science ®Google Scholar
• DalalAAChristensenLLiuFRiedelAADirect costs of chronic obstructive pulmonary disease among managed care patientsInt J Chron Obstruct Pulmon Dis2010534134921037958
   PubMedGoogle Scholar
• MiravitllesMMurioCGuerreroTGisbertRDAFNE Study GroupDecisiones sobre Antibioticoterapia y Farmacoeconomía en la EPOC. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPDChest200212151449145512006427
   PubMed Web of Science ®Google Scholar
• SchermerTRSarisCGvan den BoschWJExacerbations and associated healthcare cost in patients with COPD in general practiceMonaldi Arch Chest Dis200665313314017220102
   PubMedGoogle Scholar
• CouillardSLarivéePCourteauJVanasseAEosinophils in COPD Exacerbations Are Associated With Increased ReadmissionsChest2017151236637327746201
   PubMed Web of Science ®Google Scholar
• BafadhelMPavordIDRussellREKEosinophils in COPD: just another biomarker?Lancet Respir Med20175974775928601554
   PubMed Web of Science ®Google Scholar
• SuissaSdell’anielloSErnstPLong-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax2012671195796322684094
   PubMed Web of Science ®Google Scholar
• TWHoTsaiYJHINT Study GroupIn-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based studyPLoS One2014912e11486625490399
   PubMed Web of Science ®Google Scholar
• PoderTGKouakouCRCBouchardPACost-effectiveness of FreeO2 in patients with chronic obstructive pulmonary disease hospitalised for acute exacerbations: analysis of a pilot study in QuebecBMJ Open201881e018835
   Web of Science ®Google Scholar
• Régie de l’assurance maladie du QuébecManuel des médecins omnipraticiens (no 100)2015 Available from: http://www.ramq.gouv.qc.ca/SiteCollectionDocuments/professionnels/manuels/100-facturation-omnipraticiens/000_complet_acte_omni.pdf
   Google Scholar
• Régie de l’assurance maladie du QuébecManuel des médecins spécialistes (no 150)2016 Available from: http://www.ramq.gouv.qc.ca/SiteCollectionDocuments/professionnels/manuels/150-facturation-specialistes/000_complet_acte_spec.pdf
   Google Scholar
• Régie de l’assurance maladie du QuébecManuel des médecins spécialistes services de laboratoire en établissement (no 170)2016 Available from: http://www.ramq.gouv.qc.ca/SiteCollectionDocuments/profes-sionnels/manuels/170-sle-specialistes/000_manuel_complet_sle_spec.pdf
   Google Scholar
• SinghDKolsumUBrightlingCELocantoreNAgustiATal-SingerRECLIPSE investigatorsEosinophilic inflammation in COPD: prevalence and clinical characteristicsEur Respir J20144461697170025323230
   PubMed Web of Science ®Google Scholar
• Vedel-KroghSNielsenSFLangePVestboJNordestgaardBGBlood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population StudyAm J Respir Crit Care Med2016193996597426641631
   PubMed Web of Science ®Google Scholar
• D’HooreWBouckaertATilquinCPractical considerations on the use of the Charlson comorbidity index with administrative data basesJ Clin Epidemiol19964912142914338991959
   PubMed Web of Science ®Google Scholar
• BloughDKRamseySDUsing Generalized Linear Models to Assess Medical Care CostsHealth Serv Outcomes Res Methodol200012185202
   Google Scholar
• HumphreysBRDealing With Zeros in Economic DataUniversity of Alberta, Department of Economics2013 Available from: https://pdfs.semanticscholar.org/35c3/8229c8f7393acffc93b4a83120661df1f02c.pdfAccessed September 10, 2018
   Google Scholar
• SteerJGibsonJBourkeSCThe DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary diseaseThorax2012671197097622895999
   PubMed Web of Science ®Google Scholar
• BafadhelMGreeningNJHarvey-DunstanTCBlood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPDChest2016150232032826851799
   PubMed Web of Science ®Google Scholar
• PrinsHJDuijkersRLutterRBlood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPDRespir Med201713111812428947018
   PubMed Web of Science ®Google Scholar
• DumanDAksoyEAgcaMCThe utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophiliaInt J Chron Obstruct Pulmon Dis2015102469247826648709
   PubMed Web of Science ®Google Scholar
• Serafino-AgrusaLScichiloneNSpataforaMBattagliaSBlood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control studyPulm Pharmacol Ther201637899426996272
   PubMed Web of Science ®Google Scholar
• YangZNortonECStearnsSCLongevity and health care expenditures: the real reasons older people spend moreJ Gerontol B Psychol Sci Soc Sci2003581S2S1012496303
   PubMed Web of Science ®Google Scholar
• DaneaultSFournierJGravité clinique, niveau d’accès et NIRRULongueuilAgence de la santé et des services sociaux de la Montérégie2014 Available from: http://extranet.santemonteregie.qc.ca/depot/document/3612/Gravit%C3%A9_niveau_acces_NIRRU_APR-DRG_2014-04-04.pdfAccessed September 10, 2018
   Google Scholar
• Global Strategy for the Diagnosis, Management and Prevention of COPDGlobal Initiative for Chronic Obstructive Lung Disease (GOLD)2018 Available from: https://goldcopd.org
   Google Scholar
• BourbeauJBhutaniMHernandezPCTS position statement: Pharmacotherapy in patients with COPD – An updateCanadian J Respir Crit Care Sleep Med201714222241
   Web of Science ®Google Scholar
• MiravitllesMSoler-CataluñaJJCalleMSpanish COPD Guidelines (GesEPOC) 2017. Pharmacological Treatment of Stable Chronic Obstructive Pulmonary DiseaseArchivos de Bronconeumología (English Edition)2017536324335
   PubMed Web of Science ®Google Scholar